source
- Biogen makes up to $1B deal for secretive anti-inflammatory biotechBiogen will pay as much as $1 billion — “predominantly” in milestone payments — to acquire a San Diego biotech that has disclosed little about its pipeline. The startup, RayThera, debuted last year…Endpoints · 1mo ago↗ source
- FDA Approves First Single-Dose Generic Treatment for InfluenzaThe U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in…fda press · 1mo ago↗ source
- FDA gives rejected drugs another chance in post-Makary eraDid you receive a complete response letter in the past year? Now may be the time for a resubmission. In the wake of FDA Commissioner Marty Makary's departure last month, the agency has already agre…